Biofilm lifestyle of Candida: a mini review

Oral Diseases - Tập 14 Số 7 - Trang 582-590 - 2008
CJ Seneviratne1, LJ Jin1, LP Samaranayake1
1Oral Bio-Sciences, Faculty of Dentistry, The University of Hong Kong, Hong Kong

Tóm tắt

Candida is the major fungal pathogen of humans causing a variety of afflictions ranging from superficial mucosal diseases to deep seated mycoses. Biofilm formation is a major virulence factor in the pathogenicity of Candida, and Candida biofilms are difficult to eradicate especially because of their very high antifungal resistance. Consequently, research into the pathogenicity of Candida has focused on the prevention and management of biofilm development, their architecture, and antifungal resistance. Although studies have shed some light, molecular mechanisms that govern biofilm formation and pathogenicity still await full clarification. This review outlines the key features of what is currently known of Candida biofilm development, regulation and antifungal resistance and, their proteomics.

Từ khóa


Tài liệu tham khảo

10.1128/AAC.48.10.4073.2004

10.1099/jmm.0.46569-0

10.1128/IAI.72.10.6023-6031.2004

10.1128/AAC.46.11.3591-3596.2002

10.1128/AAC.42.8.1900

10.1099/00222615-48-7-671

10.1093/jac/46.3.397

Banerjee SN, 1991, Secular trends in nosocomial primary blood‐stream infections in the United‐States, 1980–1989, Am J Med, 91, S86, 10.1016/0002-9343(91)90349-3

10.1093/infdis/167.5.1247

10.1007/s00284-005-4552-3

10.1371/journal.pgen.0010001

10.1128/JB.183.18.5385-5394.2001

10.1128/AEM.71.12.8795-8801.2005

10.1128/JCM.00773-06

10.1146/annurev.mi.49.100195.003431

10.1128/CMR.15.2.167-193.2002

10.1086/520192

10.1093/nar/gki124

10.1128/EC.3.2.536-545.2004

10.1089/109629603322419607

10.1111/j.1574-6941.2005.00045.x

10.1128/AEM.02711-06

10.1111/j.1574-6968.2007.00745.x

Hawser SP, 1994, Biofilm formation by Candida species on the surface of catheter materials in‐vitro, Infect Immun, 62, 915, 10.1128/iai.62.3.915-921.1994

10.1128/AAC.39.9.2128

10.1099/00222615-47-3-253

10.1128/AEM.02439-06

10.1128/JCM.41.7.2961-2967.2003

10.1111/j.1365-2591.1981.tb01073.x

10.1016/S0378-1097(03)00856-5

10.1128/JB.186.24.8172-8180.2004

10.1128/IAI.70.2.878-888.2002

10.1128/AAC.46.6.1773-1780.2002

10.1016/S1369-5274(02)00371-5

10.1080/13693780500338084

10.1128/AAC.00684-06

10.1128/IAI.71.8.4333-4340.2003

10.1128/IAI.00161-06

10.1128/EC.4.9.1562-1573.2005

10.3109/08910609609167727

10.1111/j.1365-2842.1997.tb00379.x

10.1111/j.1462-5822.2006.00761.x

10.1128/EC.00194-06

Odds FC, 1998, Candida and candidosis

10.1111/j.1600-0463.2006.apm_394.x

10.1034/j.1399-3062.1999.010405.x

Pitarch A, 2006, Candida albicans biology and pathogenicity: insights from proteomics, Methods Biochem Anal, 49, 285, 10.1002/0471973165.ch17

10.1126/science.283.5409.1837

10.1016/S0300-5712(97)00034-1

10.1128/JCM.39.9.3234-3240.2001

10.1128/AAC.45.9.2475-2479.2001

10.1111/j.1574-6968.2002.tb11330.x

10.1111/j.1567-1364.2006.00117.x

10.1034/j.1600-051x.2001.028009860.x

10.1128/EC.4.8.1493-1502.2005

10.1016/0003-9969(81)90178-3

Samaranayake LP, 1990, Oral Candidosis

10.1099/00222615-17-1-13

10.1111/j.1699-0463.1995.tb01427.x

10.1034/j.1601-0825.8.s2.6.x

10.1128/JCM.43.2.818-825.2005

Serefko A, 2006, In vitro activity of caspofungin against planktonic and sessile Candida sp. cells, Pol J Microbiol, 55, 133

10.1128/JCM.40.4.1244-1248.2002

10.1016/j.tripleo.2003.12.022

10.1016/j.archoralbio.2007.01.009

10.1002/pmic.200600332

10.2174/187152606779025815

10.1016/0142-9612(96)89780-8

10.1007/s11046-005-0167-2

10.1086/430923

10.1080/02648725.1996.10647923

10.1099/mic.0.27763-0

Thông tin
Thông tin xuất bản

Oral Diseases

Tập 14 Số 7

582-590

Thông tin tác giả